Evidence map›Paper›PMID 36832155›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Automated Contouring and Planning in Radiation Therapy: What Is 'Clinically Acceptable'?

Hana Baroudi, Kristy K Brock, Wenhua Cao, Xinru Chen, Caroline Chung, Laurence E Court, Mohammad D El Basha, Maguy Farhat, Skylar Gay, Mary P Gronberg and 18 more

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A Real-World Evaluation of Failure Detection for Liver CT Segmentation.medRxiv : the preprint server for health sciences · 2026
    Article
  10. Article
  11. Automated vs. manual segmentation for small renal mass imaging.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Hana BaroudiDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kristy K BrockDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-9364-5040
Wenhua CaoDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xinru ChenDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-9989-8943
Caroline ChungDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Laurence E CourtDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-3241-6145
Mohammad D El BashaDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Maguy FarhatDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Skylar GayDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-4659-0766
Mary P GronbergDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-0121-9579
Aashish Chandra GuptaDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Soleil HernandezDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-1934-8157
Kai HuangDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-7683-5093
David A JaffrayDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-7378-7543
Rebecca LimDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Barbara MarquezDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kelly NealonDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Tucker J NethertonDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Callistus M NguyenDepartment of Imaging Physics, Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Brandon ReberThe University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Dong Joo RheeDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ramon M SalazarDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mihir D ShankerThe University of Queensland, Saint Lucia 4072, Australia.
Carlos SjogreenDepartment of Physics, University of Houston, Houston, TX 77004, USA.
McKell WoodlandDepartment of Imaging Physics, Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-0995-3695
Jinzhong YangDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cenji YuDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Yao ZhaoDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-8863-841X

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.P01CA261669 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TITT, UWE · 2021 to 2025
$14.0M
Optimization and Evaluation of Anatomical Models of Liver Radiation ResponseR01CA221971 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BROCK, KRISTY · 2018 to 2022
$1.8M
Anatomical Modeling to Improve the Precision of Image Guided Liver AblationR01CA235564 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BROCK, KRISTY, ODISIO, BRUNO C · 2019 to 2023
$1.7M
NCI NIH HHS P01 CA261669NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA221971NCI NIH HHS R01 CA235564
6 · The paper itself

Abstract

Developers and users of artificial-intelligence-based tools for automatic contouring and treatment planning in radiotherapy are expected to assess clinical acceptability of these tools. However, what is 'clinical acceptability'? Quantitative and qualitative approaches have been used to assess this ill-defined concept, all of which have advantages and disadvantages or limitations. The approach chosen may depend on the goal of the study as well as on available resources. In this paper, we discuss various aspects of 'clinical acceptability' and how they can move us toward a standard for defining clinical acceptability of new autocontouring and planning tools.

Indexed as

artificial intelligencequality assuranceradiotherapy treatment planning

Identifiers

PMID36832155
PMCPMC9955359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.